Genenta Science SpA Sponsored ADR (GNTA) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Genenta Science’s proposed loyalty share program presents a considerable risk by potentially reducing the liquidity of its American Depositary Shares (ADSs). This program may concentrate voting power among a small group of long-term, registered shareholders, thereby diluting the influence of ADS holders on corporate decisions. Such concentration of power could deter investors seeking control or aiming to instigate changes in management or company strategy. Moreover, the program’s structure could discourage takeover bids, possibly affecting the market value of Genenta Science’s ADSs unfavorably.
Overall, Wall Street has a Moderate Buy consensus rating on GNTA stock based on 2 Buys.
To learn more about Genenta Science SpA Sponsored ADR’s risk factors, click here.
